FDA Inspection 1060984 — Aamir Z. Jamal, MD
The FDA completed an inspection of Aamir Z. Jamal, MD on July 20, 2018 in San Dimas, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Dimas, CA (United States)
Additional Details
Clinical Investigator (CI)